The bill provides sustained funding, data, and temporary prosecutorial support to bolster fentanyl interdiction and prosecutions—potentially reducing overdose harms—but it increases federal spending, administrative burdens, risks diverting existing justice resources, and centralizes some decision-making with attendant privacy and local-control concerns.
State, local, Tribal, and federal law enforcement will get targeted assistance and coordination for fentanyl interdiction, which can increase seizures and reduce community overdoses and harms.
All HIDTAs and associated law enforcement operations receive sustained funding certainty through a $333 million annual authorization for FY2025–2030, enabling longer-term planning and program stability.
Law enforcement agencies and prosecutors will receive clearer fentanyl-specific data via an annual HIDTA report, improving understanding of trafficking patterns and evidence-based targeting of investigations.
Taxpayers will bear the cost of a $333 million annual authorization for FY2025–2030, increasing federal spending and potentially adding to deficit pressures.
Temporary reassignment of assistant U.S. attorneys and other DOJ resources to fentanyl cases could divert prosecutorial capacity from non-fentanyl cases, slowing other federal prosecutions.
Expanded HIDTA reporting requirements increase administrative workload for local and regional task forces, potentially diverting limited operational time and resources away from investigations.
Based on analysis of 2 sections of legislative text.
Requires fentanyl-focused HIDTA reporting, authorizes $333M/year for FY2025–2030, expands interdiction purposes, and directs DOJ to provide temporary prosecutorial resources through FY2030.
Introduced February 27, 2025 by Mark Edward Kelly · Last progress February 27, 2025
Expands reporting, funding, and operational support for the High Intensity Drug Trafficking Areas (HIDTA) program to strengthen fentanyl interdiction. It requires annual HIDTA reports specifically on fentanyl investigations, seizures, prosecutions, and regional trafficking trends; mandates HIDTA reports to identify limitations and recommend fixes; authorizes $333 million per year for FY2025–2030; broadens statutory purposes to emphasize fentanyl interdiction; and directs the Attorney General to make investigative and prosecutorial resources (including temporary reassignment of assistant U.S. attorneys) available for FY2024–2030 with a reassignment process to be established within 180 days of enactment. These changes increase federal reporting and oversight, provide multi-year funding authorization, and create a mechanism to move DOJ prosecutorial and investigative resources to support HIDTA investigations focused on fentanyl and related substances.